MAP1LC3A and neoplasm: Out of the thirteen pairs of PCa specimens, 8 (62%) showed a significant increase in LC3 expression (average LC3 immunoreactivity (IR) of primary and relapsed PCa tumor was 0.51 and 1.12, respectively; P<0.005) in relapsed PCa tissue comparing to their primary tumor counterpart.